| BCR antibodies | |
| This is a review about BCR antibodies, based on 5 published articles using BCR antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited BCR antibody. Information in this review (with links to publications) can be searched freely. |
CELL SIGNALING TECHNOLOGY search Cell Signaling Technology BCR products
includes other brands or spellings
|
| wb | | Cell Signaling rabbit polyclonal anti-phospho-Bcr antibody was used in western blot to detect phospho-Bcr in K562-R, LAMA-R and their parent cells treated with 1 µM imatinib mesylate. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology BCR products
includes other brands or spellings
|
| ic, ip, wb | | Santa Cruz Biotechnology rabbit polyclonal anti-Bcr antibodies C20 and N20 were used in immunoprecipitation, western blot and immunocytochemistry to study the interaction of Bcr kinase and AF-6 and the effects of them on Ras signaling. |
| wb | | Santa Cruz Biotechnology polyclonal antibody against BCR was used in western blot to identify a member of forkhead transcription factor FKHRL1 as a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells. |
EMD BIOSCIENCES search EMD Biosciences BCR products
includes other brands or spellings
|
| ip, wb | | Oncogene anti-Bcr antibody was used in western blot and immunoprecipitation to study the interaction of Dok-R and c-Abl. |
CN BIOSCIENCES
|
| wb | | CN Biosciences anti-Bcr antibody was used in western blot to detect Bcr in U937, Jurkat, and K562 cell lysates. |
Articles Reviewed |
| 1. Zaruhi Poghosyan et al. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases. 2002 |
| 2. Norio Komatsu et al. A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells. 2003 |
| 3. Zubin Master et al. Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization. 2003 |
| 4. G Radziwill et al. The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain. 2003 |
| 5. Yun Dai et al. A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2. 2004 |
|